Scroll To Top
Search by Speciality


The Fairmont Empress * | Victoria, CANADA
From 0 to 0 CAD
Event Preview
This event
is Finished
Specialty: , Obstetrics and Gynecology, Urology
Dates: From Sep, 26, 2013 to Sep, 29, 2013
Location: Victoria, CANADA
Type: Meeting
Registration Cost: From 0 to 0 CAD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Victoria, Canada.
General Info
Event Venue:

The Fairmont Empress *

Victoria, CANADA Visit the Venue to read more


CFAS is an Accredited Provider for Group Learning Activities Under Section 1 as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

The CFAS Annual Meeting is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada

Event Overview
Welcome message:

Dear colleagues and friends of CFAS,

You are cordially invited to join us in Victoria in 2013. The beautiful city of Victoria has been selected for next year’s Annual Meeting and I am certain you will enjoy the exceptional facilities at the Empress Victoria Fairmont Hotel.

The theme of "Quality and Safety" promises to be informative, challenging and current for our speciality and the patients we serve.

Your Scientific Program Committee is working hard to make your time with us rewarding, and Vancouver Island will provide the backdrop to a wonderful time of friendship and academic exchange.

We are looking forward to your participation and presence.

See you in Victoria!

Matt Gysler, MD
CFAS President 2012-2013

Registration Not yet available Register Now
Scientific Content Up to Date
Scientific Program:
Submission Info
  • An Ethical Standards Disclosure Form for the presenter and EACH author must be enclosed with each abstract submitted
  • NO abstracts submitted on paper will be accepted.
  • NO faxed abstracts will be accepted.
  • NO emailed abstracts will be accepted. (Do not email abstracts to the CFAS office.)

Abstracts submitted must contain original work and must not have been published previously or presented at a meeting of another national or international scientific organization prior to this meeting.

All individuals who require a visa to enter Canada are urged to begin making travel arrangements and obtaining necessary papers now to attend the meeting. A letter inviting any individual who wishes to attend may be obtained by request at The letter does not imply any financial support by CFAS.

All abstracts must be submitted through the electronic online Abstract Submitter. Please be sure to review the submission criteria before submitting your abstract. If you require more information please contact the CFAS Office:

Canadian Fertility & Andrology Society
1255 University, Suite 1107
Montreal, QC H3B 3W7
Phone: 514-524-9009
Fax: 514-524-2163

Editorial Guidelines for Presented Content:

Abstracts should be submitted in English only.

The success of any scientific meeting depends upon the quality of not only its plenary lectures, but also the free communications contributed by the registrants. Consequently, much thought has been devoted to ensuring that our meeting will provide the best possible forum for registrants to present their new and exciting research and clinical results.

As with every meeting there is a finite amount of time that can be dedicated in the program for presentation of oral free communications and many registrants’ work has to be assigned to poster presentations. Abstracts will be subject to anonymous peer review by 3 or more referees and, in general, those with the highest scores will be assigned oral presentation format.

Other accepted abstracts will be assigned to poster format presentation. If you are not willing to accept either an oral or a poster format presentation, you must indicate this at the time of submission. For Poster presentation guidelines please click here.

Any topic relevant to human reproduction, assisted conception or reproductive genetics will be considered for inclusion in the meeting program. Abstracts must report results of a study or investigation. Any abstract not including adequate data, or saying that “results will be presented / discussed” will not be accepted. Appropriate statistical analysis of data must be presented.

Material submitted should not have been presented at a national or international meeting or published prior to our meeting.

By submitting an abstract, authors warrant that the work was conducted in complete accordance with any and all local, national and international ethical guidelines or regulations, including the Nuremberg Code and the Declaration of Helsinki.

To view a sample abstract please click here.

Use a structured layout for the abstract including headings (in bold): Introduction, Materials and Methods, Results, Discussion (or Conclusions), and References (if applicable).

Authorship of abstracts should conform to international standards. Read more »»

The abstract should be typed single-spaced with one line of space between paragraphs and headings. Do not indent paragraphs.

The body of the document should be no more than 375 words (2200 characters, including spaces).

Please make sure that the abstract file document is in .doc or .docx format.

Introduction - should be informative and short, stating why the study was conducted.

Material & methods - indicating the locale, number and type of human subjects, non-human species or material being studied, the principal procedures, assays, tests or treatments performed.

Results - confirming or refuting the hypothesis, supported by statistics if appropriate.

Conclusions - stating the major new findings of the study and specifying what these findings add to what is known already.

References - if applicable.

Abstract style:

Type the title in bold, authors in italics, and body in normal text.

Do not use capital letters and do not indent.

The title should reflect the contents and should be no longer than 150 characters.

List all authors first name followed by family name followed by affiliation. 
(i.e. John Campbell1, Margaret Witherspoon2
 University of Toronto, Ontario, Canada, 2 Fertility Clinic, Red Deer, Alberta, Canada)

The name of the first author is also the presenting author.

Do not include professional titles or degrees.

Graphic elements such as tables and graphs should be included in your document. However, please DO NOT incorporate any large graphic elements, as this will limit the amount of words you may include.

As a guide, all text and graphics must fit within a 7.5" by 8" box.

Abbreviations, acronyms and units:

Standard abbreviations and acronyms may be used without prior definition (e.g. IVF, OPU, GnRH, FSH, HSA, etc), but all non-standard terms must be defined where first used in the text.

SI units should be used throughout.

Identify significant differences using an italic capital letter “P”, e.g. P

Please check your abstract carefully; it will be published as submitted.


An Ethical Standards Disclosure Form for the presenter and EACH author must be completed for each submitted abstract.

All abstracts will be evaluated blindly by the Program Committee.

You will be notified by email by the end of May 2013 as to whether or not your abstract has been accepted for presentation and you will be provided with details regarding designation (i.e., oral or poster), classification, and time allocation.

Only registered meeting participants will be accepted as abstract presenters. Submission of an abstract indicates acceptance of and compliance with the abstract submission guidelines.

Abstract will NOT be included in the program unless the presenting author register for the meeting 
no later than June 15, 2013

Submission Procedure 
Please read the instructions carefully and follow the steps for submission. For each step, make sure that all required fields are completed before moving on to the next step.

Sponsors Exhibitors
General Info

The CFAS Annual Meeting is an important forum for the presentation and discussion of new developments in reproductive medicine and science.

An extensive exhibition will accompany the meeting, enabling delegates to review the ever-developing scientific innovations associated with these fields.

The Meeting objective is to bring together all those concerned with development in the field of reproductive medicine and science:

  • healthcare practitioners,
  • researchers,
  • pharmaceutical industries and material manufacturers.
Exhibition Housing Info
All booths will be set up in Carson Hall at the Victoria Convention Centre. Standard booth space measures 8 ft. x 10 ft. and is available in multiples of this size. The exhibit hall is carpeted.

Rental of the standard exhibit space includes:

  • Booth draping
  • One 6 ft. draped table with two chairs and wastebasket
  • Exhibitor name on booth
  • Promotion of the conference
  • Exhibitor’s manual
  • Daily cleaning of public areas and booths
  • Listing in official meeting documents
  • Two complimentary exhibitor registrations (per booth)
  • One complimentary Final Program/Syllabus (per booth)
  • Lunch and health breaks
Breaks and lunches in the exhibit hall and tailored exhibit hours are planned to ensure heavy traffic.

Standard Booth
$2,500 CAD [plus tax(es)] by December 31, 2012
$2,750 CAD [plus tax(es)] after December 31, 2012
Payment in full is due at the time of reservation.

Space Assignment
Sponsors at the Champion, Platinum and Gold levels will be given first priority in the allocation of booth space. Remaining booth space will be allocated on a first come, first served basis. For more information on sponsorship, please click here.

Cancellation Policy*
Written notice of cancellation received by CFAS before March 15, 2013, entitles an exhibitor to a full refund less a $200 processing fee. If space is reduced, the net reduction of space will be treated as a cancellation of space. No refund is made for cancellations received after March 15, 2013. However, in the event the cancelled space(s) is (are) resold and the entire exhibit space is sold out, CFAS will refund 90% of the cancelled exhibitor’s payment.
Exhibit hours, program

Move-In: Thursday, September 26, starting at 13h

Exhibit Hours: 
Friday, September 27, 09h – 16h 
Saturday, September 28, 09h – 16h

Move-Out: Saturday, September 28, starting at 19h


Exhibition Floor plans
Organising Agency

Contact: , Canadian Fertility & Andrology Society

Phone: 514-524-9009

Fax: 514-524-2163

Event map
Revelant Events